| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/25/2002 | US20020099017 Gene designated EXP189 encoding an intercellular adhesion molecule; protein encoded by EXP189 used for diagnostic screening, for treating respiratory and inflammatory disorders, and for detecting genetic abnormalities |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099014 Method for treatment of insulin resistance in obesity and diabetes |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099010 Neurogenic compositions and methods |
| 07/25/2002 | US20020099009 Also diagnosing or detecting apoptosis as well as antibodies directed against the protein. |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020099005 Mucin is present in a natural or modified form; includes delivery of DNA, RNA, PNA, polynucleotides and proteins into cells, tissues or organisms; gene therapy; customized therapeutics; vaccination; drug delivery |
| 07/25/2002 | US20020099004 Inhibiting or abolishing the protein cleaving action of plasmin, and inhibiting or abolishing the protein cleaving action of a murine metalloprotease. |
| 07/25/2002 | US20020099002 Diagnostic and therapeutic methods utilizing antiangiogenic agents which bind Gb3 or CD77, e.g., verotoxins; treating multiple drug resistant tumors |
| 07/25/2002 | US20020099001 Proteins attached to three or more polymer molecules (e.g., polyethylene glycol), providing resistance against proteolysis and allows uptake into the blood; especially modified G-CSF and consensus interferon. |
| 07/25/2002 | US20020099000 Fibrinolytic or anticoagulant drugs are biocompatibly coupled to red blood cell carriers. |
| 07/25/2002 | US20020098999 Compounds for sustained release of orally delivered drugs |
| 07/25/2002 | US20020098583 Composition for use in the treatment of cell cycle defects, autoimmune diseases, aging, cancer, leukemia and psoriasis |
| 07/25/2002 | US20020098582 Differentiated stem cells suitable for human therapy |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098577 Nucleotide sequences coding enzymatic polypeptide for use in treating cell proliferation and differentiation defects |
| 07/25/2002 | US20020098568 Zcys7: a member of the cystatin superfamily |
| 07/25/2002 | US20020098566 Human nucleolin-like protein |
| 07/25/2002 | US20020098563 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 07/25/2002 | US20020098561 Polypeptide for use in the treatment of thrombosis and arteriosclerosis |
| 07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
| 07/25/2002 | US20020098550 Nucleotide sequences coding membrane protein for use in treatment and prevention of endotoxin shock, viral disease, immflammation and tumors |
| 07/25/2002 | US20020098549 Mouse EDG1 |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098541 TNFR related gene 12 |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098530 Tumor suppressor gene |
| 07/25/2002 | US20020098525 Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 |
| 07/25/2002 | US20020098524 Screening peptide library for preferential proteins; obtain library, incubate with antitarget, separate unbound peptides, incubate unbound peptides with target binding protein, detect bound peptide complexes |
| 07/25/2002 | US20020098522 RIP: novel human protein involved in tumor necrosis factor signal transduction |
| 07/25/2002 | US20020098515 Antibody for use in the treatment of cancers and leukemias |
| 07/25/2002 | US20020098486 Novel human transferase proteins and polynucleotides encoding the same |
| 07/25/2002 | US20020098474 Human short-chain dehydrogenase |
| 07/25/2002 | US20020098469 Extracorporeal methods for enhancing antigen presentation and immune responsiveness |
| 07/25/2002 | US20020098277 Proteins are reduced with thiol redox proteins and further reacted with cystamine or oxidized glutathione to prevent reoxidation |
| 07/25/2002 | US20020098253 Oral compositions containing lotus |
| 07/25/2002 | US20020098237 Neurotoxin implant |
| 07/25/2002 | US20020098234 Comprises lytic enzyme for the infecting bacteria (Listeria, Salmonella, Escherichia coli, and Campylobacter) carried via suppository enemas, syrups, or enteric coated pills |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098219 For treating xeric stress, comprising mixtures of ceramides and essential and nonessential free fatty acids, and mixtures of a beta - glucoerebrosidase and a phopholipase A2 |
| 07/25/2002 | US20020098206 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 07/25/2002 | US20020098203 Immnunologically active substance embedded in microparticles consisting of starch with amylopectin content greater than 85%; non-crosslinked |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098200 Polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA encoding said proteins |
| 07/25/2002 | US20020098197 Hla binding peptides and their uses |
| 07/25/2002 | US20020098196 Pseudomonas treatment composition and method |
| 07/25/2002 | US20020098195 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 07/25/2002 | US20020098191 Expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer |
| 07/25/2002 | US20020098189 Have specificity for antigens displayed by microorganisms, especially viruses, as well as antigenic sites present on cancer cells and on various types of toxins, and products of toxins |
| 07/25/2002 | US20020098187 Vascular endothelial cell growth factor antagonists |
| 07/25/2002 | US20020098185 Administering therapeutically effective amount of IL-18 antagonist; treatment of rheumatoid arthritis, inflammatory bowel disease |
| 07/25/2002 | US20020098183 Administering anti-L-selectin antibody in pharmaceutically acceptable carrier to patient in amount sufficient to reduce multiple organ failure, wherein first dose is administered from 0.5 to 8 hours after polytraumatic event |
| 07/25/2002 | US20020098179 Pharmaceutical combinations |
| 07/25/2002 | US20020098178 Short term treatment with composition having gastrin/cholecystokinin receptor ligand and EGF receptor ligand, resulting in prolonged period of increased insulin release |
| 07/25/2002 | US20020098177 17867, a novel human aminopeptidase |
| 07/25/2002 | US20020098176 Inhibition of tumor growth by a nematode anticoagulant protein |
| 07/25/2002 | US20020098175 Hypocholesterolemic agent, hypotriglyceride agent, lipasic and proteasic agents, hypoglycemic agent, hydrocoleretic agent; for ketogenic diet |
| 07/25/2002 | US20020098174 Anticancer agents |
| 07/25/2002 | US20020098173 Amyloid modulators of an A beta aggregation core domain and a modifying group coupled to it |
| 07/25/2002 | US20020098171 Non-specific stimulation of the immune system or the regenerative mechanisms of the human or animal body to treat or prevent diseases of leukemia, hair growth disorder, a fish and a bee disease |
| 07/25/2002 | US20020098167 Administration of stem cells with cytokines |
| 07/25/2002 | US20020098166 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 07/25/2002 | US20020098164 Treatment of tumor metastases and cancer |
| 07/25/2002 | US20020098163 Isolated nucleic acid molecules used for immunotherapy |
| 07/25/2002 | US20020098162 Decoy which antagonizes the nucleic acid domain to which NF-kappa B is bound; antiischemic, inflammatorie, anticancer agents and treatment of cachexia and autoimmune diseases |
| 07/25/2002 | DE10144711A1 Mixture of microbial lipase, protease and amylase, useful for improving digestion in cases of pancreatic insufficiency |
| 07/25/2002 | DE10141198A1 Prophylaktisches und therapeutisches antivirales Medikament gegen Aids, Hepatitis B, Hepatitis C und Influenza Prophylactic and therapeutic antiviral drug against AIDS, hepatitis B, hepatitis C and influenza |
| 07/25/2002 | DE10103271A1 Pharmaceutical formulation containing hyaluronatlyase, useful for softening of connective tissue in medical and cosmetic treatment, especially in shape correction |
| 07/25/2002 | DE10101529A1 A solution of cyclosporin in neutral oil, preferably medium chain triglyceride, is useful as an immunosuppressive agent |
| 07/25/2002 | CA2450929A1 Vegfr-3 binding peptides and their use for inhibiting angiogenesis |
| 07/25/2002 | CA2440317A1 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 07/25/2002 | CA2437082A1 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | CA2435374A1 Presbyopia treatment by reducing and preventing lenticular disulfide crosslinks |
| 07/25/2002 | CA2435283A1 Method for identifying compounds modulating sister chromatid separation |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435248A1 Drug composition for the promotion of tissue regeneration |
| 07/25/2002 | CA2435200A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | CA2435037A1 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | CA2434803A1 Screens and assays for agents useful in controlling parasitic nematodes |
| 07/25/2002 | CA2434099A1 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433803A1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces |
| 07/25/2002 | CA2433316A1 Molecular antigen array |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
| 07/25/2002 | CA2431991A1 Impact modified polyamide composition |
| 07/25/2002 | CA2431919A1 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | CA2406342A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225224A1 Shear stress-response dna |
| 07/24/2002 | EP1225223A1 p21Cip1 REMEDIES FOR RHEUMATISM |
| 07/24/2002 | EP1225222A1 Novel tumor suppressor gene |
| 07/24/2002 | EP1225220A1 Dna encoding endo-beta-galactosidase |
| 07/24/2002 | EP1225184A1 Human antithrombin variants |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |